Heart, Lung and Circulation

New Minimally Invasive and Tailor-Made Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation

Published:November 06, 2021DOI:


      The optimal dosage for cryoballoon ablation (CBA) of atrial fibrillation (AF) is still unknown.


      This study aimed to evaluate the clinical implications of a reduction in the freezing duration to <180 seconds during CBA guided by the time to the target temperature.


      This study enrolled 325 consecutive paroxysmal AF patients who underwent CBA. It was a retrospective observational study in a single centre. It compared 164 patients who underwent a tailor-made CBA procedure (group T) with 161 who had a standard CBA procedure (group S). In group T, the freezing duration was reduced to 150 seconds when the temperature reached ≤ –40 °C within 40 seconds. Furthermore, it was reduced to 120 seconds when it reached ≤ –50 °C within 60 seconds. In the other patients, the freezing duration was 180 seconds, except for excessive freezing of ≤ –60 °C and/or emergent situations while monitoring the oesophageal temperature, and for phrenic nerve injury, as in group S.


      In group T, 89 patients (83%) underwent CBA with a reduction in the freezing duration. The total freezing time for each pulmonary vein was significantly shorter in group T than group S, and the total procedure time in group T decreased by an average of 4 minutes compared with group S. The rate of requiring additional radio frequency ablation following the CBA was significantly lower in group T than group S. The AF-free survival rate during the follow-up period (median, 366 days) was similar between the two groups.


      The safety and efficacy of the new CBA strategy were non-inferior to the standard procedure.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • Calkins H.
        • Cigarroa J.E.
        • Cleveland Jr., J.C.
        • et al.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
        Circulation. 2014; 130: 2071-2104
        • Kirchhof P.
        • Benussi S.
        • Kotecha D.
        • Ahlsson A.
        • Atar D.
        • Casadei B.
        • et al.
        2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
        Eur Heart J. 2016; 37: 2893-2962
        • Kuck K.
        • Brugada J.
        • Albenque J.
        Cryoballoon or radiofrequency ablation for atrial fibrillation.
        N Engl J Med. 2016; 375: 1100-1101
        • Casado-Arroyo R.
        • Chierchia G.B.
        • Conte G.
        • Levinstein M.
        • Sieira J.
        • Rodriguez-Manero M.
        • et al.
        Phrenic nerve paralysis during cryoballoon ablation for atrial fibrillation: a comparison between the first- and second-generation balloon.
        Heart Rhythm. 2013; 10: 1318-1324
        • Furnkranz A.
        • Bordignon S.
        • Schmidt B.
        • Perrotta L.
        • Dugo D.
        • De Lazzari M.
        • et al.
        Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients.
        Europace. 2015; 17: 574-578
        • Furnkranz A.
        • Chun K.R.
        • Metzner A.
        • Nuyens D.
        • Schmidt B.
        • Burchard A.
        • et al.
        Esophageal endoscopy results after pulmonary vein isolation using the single big cryoballoon technique.
        J Cardiovasc Electrophysiol. 2010; 21: 869-874
        • Furnkranz A.
        • Bordignon S.
        • Schmidt B.
        • Bohmig M.
        • Bohmer M.C.
        • Bode F.
        • et al.
        Luminal esophageal temperature predicts esophageal lesions after second-generation cryoballoon pulmonary vein isolation.
        Heart Rhythm. 2013; 10: 789-793
        • Kulkarni N.
        • Su W.
        • Wu R.
        How to prevent, detect and manage complications caused by cryoballoon ablation of atrial fibrillation.
        Arrhythm Electrophysiol Rev. 2018; 7: 18-23
        • Miyazaki S.
        • Nakamura H.
        • Taniguchi H.
        • Hachiya H.
        • Takagi T.
        • Igarashi M.
        • et al.
        Gastric hypomotility after second-generation cryoballoon ablation: unrecognized silent nerve injury after cryoballoon ablation.
        Heart Rhythm. 2017; 14: 670-677
        • Chun K.R.
        • Furnkranz A.
        • Koster I.
        • Metzner A.
        • Tonnis T.
        • Wohlmuth P.
        • et al.
        Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study.
        J Cardiovasc Electrophysiol. 2012; 23: 814-819
        • Miyamoto K.
        • Doi A.
        • Hasegawa K.
        • Morita Y.
        • Mishima T.
        • Suzuki I.
        • et al.
        Multicenter study of the validity of additional freeze cycles for cryoballoon ablation in patients with paroxysmal atrial fibrillation: the AD-Balloon Study.
        Circ Arrhythm Electrophysiol. 2019; 12: e006989
        • Ciconte G.
        • de Asmundis C.
        • Sieira J.
        • Conte G.
        • Di Giovanni G.
        • Mugnai G.
        • et al.
        Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation.
        Heart Rhythm. 2015; 12: 673-680
        • Ciconte G.
        • Sieira-Moret J.
        • Hacioglu E.
        • Mugnai G.
        • Di Giovanni G.
        • Velagic V.
        • et al.
        Single 3-minute versus double 4-minute freeze strategy for second-generation cryoballoon ablation: a single-center experience.
        J Cardiovasc Electrophysiol. 2016; 27: 796-803
        • Wissner E.
        • Heeger C.H.
        • Grahn H.
        • Reissmann B.
        • Wohlmuth P.
        • Lemes C.
        • et al.
        One-year clinical success of a 'no-bonus' freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation.
        Europace. 2015; 17: 1236-1240
        • Andrade J.G.
        • Champagne J.
        • Dubuc M.
        • Deyell M.W.
        • Verma A.
        • Macle L.
        • et al.
        Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial.
        Circulation. 2019; 140: 1779-1788
        • Chen S.
        • Schmidt B.
        • Bordignon S.
        • Perrotta L.
        • Bologna F.
        • Chun K.R.J.
        Impact of cryoballoon freeze duration on long-term durability of pulmonary vein isolation: ICE Re-Map Study.
        JACC Clin Electrophysiol. 2019; 5: 551-559
        • Velagić V.
        • de Asmundis C.
        • Mugnai G.
        • Hünük B.
        • Hacioğlu E.
        • Ströker E.
        • et al.
        Learning curve using the second-generation cryoballoon ablation.
        J Cardiovasc Med (Hagerstown). 2017; 18: 518-527
        • Nakano T.
        • Suenari K.
        • Suruga K.
        • Takemoto H.
        • Hashimoto Y.
        • Tomomori S.
        • et al.
        New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation.
        Eur Heart J. 2019; 40: 4760
        • Suenari K.
        • Nakano T.
        • Tomomori S.
        • Shiode N.
        • Higa S.
        • Chen S.A.
        Cryoballoon ablation for patients with paroxysmal atrial fibrillation.
        Circ Rep. 2020; 2: 75-82
        • Hojo R.
        • Fukamizu S.
        • Tokioka S.
        • Inagaki D.
        • Miyazawa S.
        • Kawamura I.
        • et al.
        Comparison of touch-up ablation rate and pulmonary vein isolation durability between hot balloon and cryoballoon.
        J Cardiovasc Electrophysiol. 2020; 31: 1298-1306
        • Calkins H.
        • Hindricks G.
        • Cappato R.
        • Kim Y.H.
        • Saad E.B.
        • Aguinaga L.
        • et al.
        2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
        Heart Rhythm. 2017; 14: e275-e444
        • Ciconte G.
        • Mugnai G.
        • Sieira J.
        • Velagic V.
        • Saitoh Y.
        • Irfan G.
        • et al.
        On the quest for the best freeze: predictors of late pulmonary vein reconnections after second-generation cryoballoon ablation.
        Circ Arrhythm Electrophysiol. 2015; 8: 1359-1365
        • Medi C.
        • Evered L.
        • Silbert B.
        • Teh A.
        • Halloran K.
        • Morton J.
        • et al.
        Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation.
        J Am Coll Cardiol. 2013; 62: 531-539
        • Yasuoka R.
        • Kurita T.
        • Kotake Y.
        • Hashiguchi N.
        • Motoki K.
        • Kobuke K.
        • et al.
        Particular morphology of inferior pulmonary veins and difficulty of cryoballoon ablation in patients with paroxysmal atrial fibrillation.
        Circ J. 2017; 81: 668-674
        • Ghosh J.
        • Martin A.
        • Keech A.C.
        • Chan K.H.
        • Gomes S.
        • Singarayar S.
        • et al.
        Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation.
        Heart Rhythm. 2013; 10: 1311-1317
        • Aryana A.
        • Mugnai G.
        • Singh S.M.
        • Pujara D.K.
        • de Asmundis C.
        • Singh S.K.
        • et al.
        Procedural and biophysical indicators of durable pulmonary vein isolation during cryoballoon ablation of atrial fibrillation.
        Heart Rhythm. 2016; 13: 424-432
        • Ciconte G.
        • Velagic V.
        • Mugnai G.
        • Saitoh Y.
        • Irfan G.
        • Hunuk B.
        • et al.
        Electrophysiological findings following pulmonary vein isolation using radiofrequency catheter guided by contact-force and second-generation cryoballoon: lessons from repeat ablation procedures.
        Europace. 2016; 18: 71-77
        • Su W.
        • Coulombe N.
        • Kirchhof N.
        • Grassl E.
        • Wittenberger D.
        Dosing of the second-generation cryoballoon using acute time-to-pulmonary vein isolation as an indicator of durable ablation in a canine model.
        J Interv Card Electrophysiol. 2018; 53: 293-300
        • Su W.
        • Aryana A.
        • Passman R.
        • Singh G.
        • Hokanson R.
        • Kowalski M.
        • et al.
        Cryoballoon Best Practices II: practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users.
        Heart Rhythm. 2018; 15: 1348-1355
        • Landolina M.
        • Arena G.
        • Iacopino S.
        • Verlato R.
        • Pieragnoli P.
        • Curnis A.
        • et al.
        Center experience does not influence long-term outcome and peri-procedural complications after cryoballoon ablation of paroxysmal atrial fibrillation: data on 860 patients from the real-world multicentre observational project.
        Int J Cardiol. 2018; 272: 130-136

      Linked Article

      • Tailored Cryoballoon Pulmonary Vein Ablation for Atrial Fibrillation: When to Stop the Freeze?
        Heart, Lung and CirculationVol. 31Issue 4
        • Preview
          Atrial fibrillation (AF) is the most common cardiac arrhythmia with an increasing prevalence and burden on the health care system [1,2]. Recently, comprehensive lifestyle and risk factor modification have been shown to reduce AF burden but there has been no new anti-arrhythmic drug discovery for many years [3]. Catheter ablation remains an attractive strategy to combat AF in patients with symptomatic AF despite lifestyle and pharmacological therapy. Although our understanding of the pathophysiological mechanisms underlying AF has improved, pulmonary vein isolation (PVI) remains the gold standard in catheter-based therapy for this complex arrhythmia as recent research aimed at targeting putative AF drivers has not shown significant incremental improvement in achieveing freedom from AF [4].
        • Full-Text
        • PDF